BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20934860)

  • 1. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
    Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.
    Jegannathen A; Mais K; Sykes A; Lee L; Yap B; Birzgalis A; Homer J; Ryder WD; Slevin N
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):149-58. PubMed ID: 20951012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End stage palliative care of head and neck cancer: a case study.
    Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
    Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
    Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
    Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Christie Regimen" palliative radiotherapy in advanced head-and-neck cancer: A single-center experience.
    Srivastava A; Adhikari N; Sonkar DR; Singh K; Rathi AK
    J Cancer Res Ther; 2021; 17(1):88-93. PubMed ID: 33723137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
    Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
    Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
    Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers.
    Murthy V; Kumar DP; Budrukkar A; Gupta T; Ghosh-Laskar S; Agarwal J
    Indian J Cancer; 2016; 53(1):138-41. PubMed ID: 27146764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
    Clavel S; Fortin B; Després P; Donath D; Soulières D; Khaouam N; Charpentier D; Bélair M; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):763-9. PubMed ID: 20510546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
    Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hypofractionated palliative radiotherapy in patients with stage four head-and-neck squamous cell carcinoma.
    Mudgal A; Arya AK; Yadav I; Chaudhary S
    J Cancer Res Ther; 2019; 15(3):528-532. PubMed ID: 31169215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
    Benhmida S; Sun R; Gherga E; Hammoud Y; Rouvier J; Mauvais O; Bockel S; Louvrier A; Lebbad A; Bontemps P; Ortholan C; Bourhis J; Lestrade L; Sun XS
    Cancer Radiother; 2020 Dec; 24(8):812-819. PubMed ID: 33144061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated palliative radiotherapy for advanced head and neck cancer: the IHF2SQ regimen.
    Monnier L; Touboul E; Durdux C; Lang P; St Guily JL; Huguet F
    Head Neck; 2013 Dec; 35(12):1683-8. PubMed ID: 23359352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split-course accelerated therapy in head and neck cancer: an analysis of toxicity.
    Delaney GP; Fisher RJ; Smee RI; Hook C; Barton MB
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):763-8. PubMed ID: 7790263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.